Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells

Infection and Immunity

Volumn 76, Issue 3, 2008, Pages 935-941

  Rivas Santiago, Bruno ^a   Hernandez Pando, Rogelio ^b   Carranza, Claudia ^c   Juarez, Esmeralda ^c   Contreras, Juan Leon ^b   Aguilar Leon, Diana ^b   Torres, Martha ^c   Sada, Eduardo ^b,c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG GRANULOMA; LUNG TUBERCULOSIS; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CHEMISTRY; CYTOPLASM; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENETICS; GRANULOMA; IMMUNOLOGY; LUNG LAVAGE; MICROBIOLOGY;

ANTIMICROBIAL CATIONIC PEPTIDES; BRONCHOALVEOLAR LAVAGE; CELL LINE; CELLS, CULTURED; CYTOPLASM; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GRANULOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES, ALVEOLAR; MICROSCOPY, IMMUNOELECTRON; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHILS; TOLL-LIKE RECEPTORS;

EID: 40749146805     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01218-07     Document Type: Article

References (43)

1. Agerberth, B., and G. H. Gudmundsson. 2006. Host antimicrobial defence peptides in human disease. Curr. Top. Microbiol. Immunol. 306:67-90.
2. Bals, R. 2000. Epithelial antimicrobial peptides in host defense against infection. Respir. Res. 1:141-150.
3. Bals, R., D. J. Weiner, R. L. Meegalla, and J. M. Wilson. 1999. Transfer of a cathelicidin peptide antibiotic gene restores bacterial lulling in a cystic fibrosis xenograft model. J. Clin. Invest. 103:1113-1117.
4. Barrios-Payan, J., D. Aguilar-Leon, R. Lascurain-Ledezma, and R. Hernandez-Pando. 2006. Neutrophil participation in early control and immune activation during experimental pulmonary tuberculosis. Gac. Med. Mex. 142:273-281.
5. Bermudez, L. E., F. J. Sangari, P. Kolonoski, M. Petrofsky, and J. Goodman. 2002. The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells. Infect. Immun. 70:140-146.
6. Carranza, C., E. Juarez, M. Torres, J. J. Ellner, E. Sada, and S. K. Schwander. 2006. Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts. Am. J. Respir. Crit. Care Med. 173:238-245.
7. Chromek, M., Z. Slamova, P. Bergman, L. Kovacs, L. Podracka, I. Ehren, T. Hokfelt, G. H. Gudmundsson, R. L. Gallo, B. Agerberth, and A. Brauner. 2006. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12:636-641.
8. Dauletbaev, N., R. Gropp, M. Frye, S. Loitsch, T. O. Wagner, and J. Bargon. 2002. Expression of human beta defensin (HBD-1 and HBD-2) mRNA in nasal epithelia of adult cystic fibrosis patients, healthy individuals, and individuals with acute cold. Respiration 69:46-51.
9. Debbabi, H., S. Ghosh, A. B. Kamath, J. Alt, D. E. Demello, S. Dunsmore, and S. M. Behar. 2005. Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cells. Am. J. Physiol. Lung Cell Mol. Physiol. 289:L274-L279.
10. Durr, U. H., U. S. Sudheendra, and A. Ramamoorthy. 2006. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta. 1758:1408-1425.
11. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677-686.
12. Ellner, J. J., C. S. Hirsch, and C. C. Whalen. 2000. Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin. Infect. Dis. 30(Suppl. 3):S279-S282.
13. Fremond, C. M., V. Yeremeev, D. M. Nicolle, M. Jacobs, V. F. Quesniaux, and B. Ryffel. 2004. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J. Clin. Invest. 114:1790-1799.
14. Hernandez-Pando, R., H. Orozcoe, A. Sampieri, L. Pavon, C. Velasquillo, J. Larriva-Sahd, J. M. Alcocer, and M. V. Madrid. 1996. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 89:26-33.
15. Houben, E. N., L. Nguyen, and J. Pieters. 2006. Interaction of pathogenic mycobacteria with the host immune system. Curr. Opin. Microbiol. 9:76-85.
16. Islam, D., L. Bandholtz, J. Nilsson, H. Wigzell, B. Christensson, B. Agerberth, and G. Gudmundsson. 2001. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7:180-185.
17. Kaufmann, S. H. 2006. Tuberculosis: back on the immunologists' agenda. Immunity 24:351-357.
18. Larrick, J. W., M. Hirata, R. F. Balint, J. Lee, J. Zhong, and S. C. Wright. 1995. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63:1291-1297.
19. Liu, P. T., S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, D. L. Kamen, M. Wagner, R. Bals, A. Steinmeyer, U. Zügel, R. L. Gallo, D. Eisenberg, M. Hewison, B. W. Hollis, J. S. Adams, B. R. Bloom, and R. L. Modlin. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 24:1770-1773.
20. Martineau, A. R., S. M. Newton, K. A. Wilkinson, B. Kampmann, B. M. Hall, N. Nawroly, G. E. Packe, R. N. Davidson, C. J. Griffiths, and R. J. Wilkinson. 2007. Neutrophil-mediated innate immune resistance to mycobacteria. J. Clin. Invest. 117:1988-1994.
21. Nizet, V., and R. L. Gallo. 2003. Cathelicidins and innate defense against invasive bacterial infection. Scand. J. Infect. Dis. 35:670-676.
22. Nizet, V., T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R. A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, and R. L. Gallo. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454-457.
23. Ong, P. Y., T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R. L. Gallo, and D. Y. Leung. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347:1151-1160.
24. Pechkovsky, D. V., T. Goldmann, E. Vollmer, J. Muller-Quernheim, and G. Zissel. 2006. Interleukin-18 expression by alveolar epithelial cells type II in tuberculosis and sarcoidosis. FEMS Immunol. Med. Microbiol. 46:30-38.
25. Platz, J., C. Beisswenger, A. Dalpke, R. Koczulla, O. Pinkenburg, C. Vogelmeier, and R. Bals. 2004. Microbial DNA induces a host defense reaction of human respiratory epithelial cells. J. Immunol. 173:1219-1223.
26. Putsep, K., G. Carlsson, H. G. Boman, and M. Andersson. 2002. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360:1144-1149.
27. Quesniaux, V., C. Fremond, M. Jacobs, S. Parida, D. Nicolle, V. Yeremeev, F. Bihl, F. Erard, T. Botha, M. Drennan, M. N. Soler, M. Le Bert, B. Schnyder, and B. Ryffel. 2004. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect. 6:946-959.
28. Raqib, R., P. Sarker, P. Bergman, G. Ara, M. Lindh, D. A. Sack, K. M. Nasirul Islam, G. H. Gudmundsson, J. Andersson, and B. Agerberth. 2006. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc. Natl. Acad. Sci. USA 103:9178-9183.
29. Rivas-Santiago, B., E. Sada, R. Hernandez-Pando, and V. Tsutsumi. 2006. Antimicrobial peptides in the innate immunity of infectious diseases. Salud Publica Mex. 48:62-71.
30. Rivas-Santiago, B., E. Sada, V. Tsutsumi, D. Aguilar-Leon, J. L. Contreras, and R. Hernandez-Pando. 2006. β-Defensin gene expression during the course of experimental tuberculosis infection. J. Infect. Dis. 194:697-701.
31. Rivas-Santiago, B., S. K. Schwander, C. Sarabia, G. Diamond, M. E. Klein-Patel, R. Hernandez-Pando, J. J. Ellner, and E. Sada. 2005. Human β-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infect. Immun. 73:4505-4511.
32. Rivas-Santiago, B., P. Vieyra-Reyes, and Z. Araujo. 2005. Cell immunity response in human pulmonary tuberculosis. Invest. Clin. 46:391-412.
33. Rosenberger, C. M., R. L. Gallo, and B. B. Finlay. 2004. Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc. Natl. Acad. Sci. USA 101:2422-2427.
34. Schauber, J., R. A. Dorschner, K. Yamasaki, B. Brouha, and R. L. Gallo. 2006. Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 118:509-519.
35. Scott, M. G., D. J. Davidson, M. R. Gold, D. Bowdish, and R. E. Hancock. 2002. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169:3883-3891.
36. Sharma, S., I. Verma, and G. K. Khuller. 2001. Therapeutic potential of human neutrophil peptide 1 against experimental tuberculosis. Antimicrob. Agents Chemother. 45:639-640.
37. Tan, B. H., C. Meinken, M. Bastian, H. Bruns, A. Legaspi, M. T. Ochoa, S. R. Krutzik, B. R. Bloom, T. Ganz, R. L. Modlin, and S. Stenger. 2006. Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J. Immunol. 177:1864-1871.
38. Turner, J., Y. Cho, N. N. Dinh, A. J. Waring, and R. I. Lehrer. 1998. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42:2206-2214.
39. van Crevel, R., T. H. Ottenhoff, and J. W. van der Meer. 2003. Innate immunity to Mycobacterium tuberculosis. Adv. Exp. Med. Biol. 531:241-247.
40. Wickremasinghe, M. I., L. H. Thomas, and J. S. Friedland. 1999. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-κB-dependent network. J. Immunol. 163:3936-3947.
41. Wu, H., G. Zhang, J. E. Minton, C. R. Ross, and F. Blecha. 2000. Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar Typhimurium infection. Infect. Immun. 68:5552-5558.
42. Yew, W. W., and C. C. Leung. 2006. Update in tuberculosis 2005. Am. J. Respir. Crit. Care Med. 173:491-498.
43. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.